Search Results 1001-1010 of 15670 for larazotide acetate
Diarrhea · loss of appetite · nausea or vomiting · pain or swelling in feet or lower legs · swelling or redness of tongue.
The purpose is to conduct a study that determines the efficiency of FMDS in pre MRI screening for detecting cardiac implants in a Mayo Clinic environment.
The transplant research group in the Division of Endocrinology, Diabetes, Metabolism, and Nutrition-Research at Mayo Clinic studies transplant in the ...
The hypothesis is that using genotypic variation in CYP2D6 to select the appropriate 5HT3 serotonin receptor antagonist to treat PONV will decrease rates of ...
About this study. This research study is being done for people who have asthma and chronic rhinosinusitis, hay fever, or you do not have any sinus disease, ...
... acetate and lenvatinib; 30 days for enzalutamide; and 95 days for olaparib, docetaxel, and carboplatin/etoposide. No contraception measures are required ...
About this study. Thep purpose of this study is to determine if 3WAVeS technology combining galvanic vestibular stimulation (GVS) and Virtual Reality (VR) ...
Teprotumumab was approved by the United States Food and Drug Administration on 21 January 2020 for the treatment of TED under the name TEPEZZA® (teprotumumab- ...
... acetate, mefloquine (Lariam®), mesoridazine (Serentil®), moxifloxacin (Avelox®), pentamidine (Nebupent®), pimozide (Orap®), probucol, procainamide ...
The purpose of this study is to assess cardiovascular health and detect unknown and asymptomatic diseases using Mayo AI-ECG algorithms. We hypothesize that ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.